Saturday 17 October 2026
Export PAHC’s income statement to Excel — free account
Phibro Animal Health Corporation
PAHC Healthcare Drug Manufacturers Specialty & Generic
Phibro Animal Health Corporation’s revenue for fiscal 2026 (year ended June 2026) was $1.5 billion, up 17.1% from fiscal 2025. In the quarter to June 2026, revenue grew 4.77%, EPS grew 28.6%, free cash flow fell 35.7% and total debt rose 1.96%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
38.82
0.84
+2.21%
Follow PAHC
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 4 | 4 | 6 | 3 | 5 | 7 | 6 | 6 |
P/E ratio |
22.59 | 29.10 | 23.25 | 32.04 | 21.55 | 15.81 | 16.91 | 284.00 | 21.46 | 12.76 |
Altman Z-Score |
4.27 | 4.75 | 3.87 | 3.16 | 3.29 | 2.84 | 2.62 | 2.61 | 2.53 | 2.95 |
P/S ratio |
1.92 | 2.30 | 1.54 | 1.33 | 1.40 | 0.82 | 0.57 | 0.68 | 0.80 | 0.84 |
Altman Z″-Score (non-manufacturers) |
4.43 | 4.69 | 4.79 | 4.15 | 4.47 | 4.49 | 4.57 | 4.20 | 3.97 | 4.70 |
P/FCF ratio |
18.89 | 36.58 | 73.96 | 42.00 | 61.56 | 0.00 | 0.00 | 14.89 | 24.74 | 129.04 |
P/Operating CF |
107.87 | 186.22 | 85.88 | 274.11 | 380.74 | 492.28 | 27.42 | 24.28 | 48.64 | 52.84 |
Beneish M-Score |
(2.73) | (2.49) | (2.31) | (2.69) | (2.32) | (2.23) | (2.44) | (2.92) | (2.35) | (2.39) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 47 |
P/B ratio |
9.69 | 10.18 | 5.92 | 5.65 | 4.90 | 2.95 | 1.96 | 2.69 | 3.62 | 3.30 |
Price to Tangible BV |
20.18 | 17.82 | 9.05 | 16.47 | 9.46 | 5.33 | 3.18 | 4.39 | 5.46 | 4.31 |
EV/Sales |
2.25 | 2.58 | 1.84 | 1.70 | 1.76 | 1.18 | 0.97 | 1.05 | 1.29 | 1.27 |
EV/EBITDA |
13.78 | 16.69 | 13.63 | 13.26 | 13.64 | 9.94 | 8.90 | 11.75 | 10.60 | 7.75 |
EV/Operating CF |
17.50 | 30.22 | 32.28 | 22.89 | 30.38 | 35.28 | 71.26 | 12.14 | 20.92 | 27.90 |
EV/FCF |
22.21 | 41.11 | 88.11 | 53.69 | 77.31 | (206.95) | (24.65) | 22.95 | 40.08 | 195.01 |
Quick Ratio |
1.57 | 1.50 | 1.56 | 1.39 | 1.46 | 1.35 | 1.39 | 1.39 | 1.04 | 1.01 |
Current Ratio |
3.14 | 2.90 | 3.02 | 2.87 | 3.04 | 2.97 | 3.33 | 2.94 | 2.76 | 2.96 |
Net Debt/EBITDA |
2.06 | 1.84 | 2.19 | 2.89 | 2.78 | 3.04 | 3.69 | 4.13 | 4.06 | 2.62 |
Debt/Assets |
50.23% | 46.51% | 44.89% | 49.36% | 46.60% | 46.47% | 48.88% | 49.69% | 52.81% | 48.81% |
Debt/Equity |
2.07 | 1.69 | 1.51 | 2.06 | 1.64 | 1.65 | 1.68 | 1.90 | 2.52 | 1.90 |
Asset Turnover |
1.24 | 1.27 | 1.18 | 1.06 | 1.03 | 1.06 | 1.03 | 1.04 | 1.11 | 1.06 |
Operating CF/Net income |
1.52 | 1.08 | 0.86 | 1.77 | 0.89 | 0.64 | 0.41 | 36.26 | 1.66 | 0.69 |
Capex/Depreciation |
(0.77) | (0.67) | (1.05) | (1.02) | (0.90) | (1.11) | (1.49) | (1.11) | (0.80) | (1.10) |
Interest Coverage |
6.57 | 8.31 | 7.07 | 5.38 | 5.81 | 6.65 | 4.69 | 2.88 | 3.19 | 4.38 |
| 53.48% | 38.61% | 27.29% | 16.60% | 25.49% | 19.63% | 11.97% | 0.90% | 17.80% | 29.72% | |
| 10.50% | 10.02% | 7.83% | 4.44% | 6.69% | 5.55% | 3.43% | 0.25% | 4.12% | 6.97% | |
ROIC |
14.99% | 14.79% | 11.29% | 8.94% | 8.71% | 8.17% | 6.64% | 5.29% | 7.45% | 11.72% |
Return on Tangible Assets |
17.22% | 16.13% | 12.10% | 7.58% | 11.11% | 9.09% | 5.39% | 0.40% | 5.54% | 10.09% |
Average Days of Receivables |
60.10 | 60.42 | 70.10 | 57.70 | 64.32 | 64.51 | 61.02 | 60.78 | 64.20 | 57.41 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
19.67% | 20.48% | 21.91% | 23.45% | 23.58% | 21.91% | 23.15% | 25.53% | 22.33% | 20.96% |
Intangible Assets out of Total Assets |
0.13 | 0.12 | 0.10 | 0.16 | 0.14 | 0.13 | 0.11 | 0.10 | 0.07 | 0.06 |
Share Based Compensation of Revenue |
0.00% | 0.04% | 0.27% | 0.28% | 0.14% | 0.00% | 0.00% | 0.05% | 0.06% | 0.11% |
Graham Net Nets |
(0.07) | (0.04) | (0.03) | (0.14) | (0.09) | (0.13) | (0.19) | (0.18) | (0.26) | (0.14) |
Graham Number |
11.88 | 12.91 | 12.79 | 9.26 | 13.33 | 13.28 | 11.27 | 2.92 | 13.74 | 22.94 |
Earnings Yield |
4.43% | 3.44% | 4.30% | 3.12% | 4.64% | 6.33% | 5.91% | 0.35% | 4.66% | 7.83% |
Free Cash Flow Yield |
5.29% | 2.73% | 1.35% | 2.38% | 1.62% | (0.70%) | (6.94%) | 6.72% | 4.04% | 0.77% |
Revenue per Share |
19.34 | 20.41 | 20.49 | 19.78 | 20.59 | 23.26 | 24.14 | 25.13 | 31.99 | 37.44 |
Operating CF per Share |
2.49 | 1.74 | 1.17 | 1.47 | 1.19 | 0.78 | 0.33 | 2.16 | 1.98 | 1.70 |
Capex per Share |
(0.53) | (0.46) | (0.74) | (0.84) | (0.72) | (0.91) | (1.28) | (1.02) | (0.95) | (1.46) |
Free Cash Flow per Share |
1.96 | 1.28 | 0.43 | 0.63 | 0.47 | (0.13) | (0.95) | 1.14 | 1.03 | 0.24 |
Cash per Share |
1.42 | 1.97 | 2.02 | 2.26 | 2.30 | 2.25 | 2.01 | 2.83 | 1.90 | 2.02 |
Shareholders Equity per Share |
3.82 | 4.60 | 5.35 | 4.65 | 5.89 | 6.48 | 6.97 | 6.34 | 7.05 | 9.51 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.82 | 4.60 | 5.35 | 4.65 | 5.89 | 6.48 | 6.97 | 6.34 | 7.05 | 9.51 |
Free Cash Flow |
77.51 | 51.46 | 17.28 | 25.30 | 18.99 | (5.39) | (38.48) | 46.36 | 41.83 | 9.87 |
Working Capital |
247.87 | 272.24 | 311.94 | 294.60 | 334.79 | 375.40 | 409.72 | 396.85 | 517.13 | 619.04 |
Capital Expenditures |
(20.88) | (18.55) | (29.89) | (34.04) | (29.32) | (37.04) | (51.79) | (41.24) | (38.29) | (59.09) |
Net Current Asset Value |
(108.57) | (71.26) | (44.49) | (144.06) | (103.89) | (103.02) | (103.16) | (124.55) | (264.61) | (180.26) |
EV/EBIT |
17.58 | 21.39 | 18.29 | 19.63 | 19.60 | 14.14 | 13.20 | 19.95 | 15.18 | 9.90 |
Capex to Sales |
0.03 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 |
Price to Operating Income |
14.95 | 19.03 | 15.35 | 15.36 | 15.61 | 9.81 | 7.72 | 12.95 | 9.37 | 6.55 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.21 | 0.21 | 0.20 | 0.22 | 0.21 | 0.20 | 0.18 | 0.18 | 0.13 | 0.15 |
Cash ROIC |
14.89% | 8.93% | 2.77% | 3.80% | 2.62% | (0.69%) | (4.59%) | 5.39% | 3.87% | 0.82% |
Accounts Receivable Turnover |
6.12 | 6.27 | 5.62 | 5.61 | 6.10 | 6.01 | 5.93 | 6.11 | 6.52 | 6.50 |
Accounts Payable Turnover |
8.82 | 9.50 | 8.49 | 7.80 | 8.36 | 8.01 | 8.02 | 8.84 | 8.01 | 7.57 |
Inventory Turnover |
3.14 | 3.26 | 2.99 | 2.75 | 2.72 | 2.76 | 2.53 | 2.59 | 2.52 | 2.05 |
Average Days of Payables |
40.24 | 39.26 | 47.42 | 44.39 | 44.40 | 53.12 | 39.66 | 44.33 | 56.28 | 46.21 |
Days of Inventory on Hand |
114.04 | 117.58 | 128.49 | 132.08 | 140.49 | 144.01 | 149.07 | 137.75 | 180.99 | 194.15 |
Average Receivables |
124.82 | 130.79 | 147.38 | 142.77 | 136.69 | 156.69 | 165.01 | 166.47 | 198.72 | 233.39 |
Average Payables |
58.53 | 58.20 | 66.34 | 69.64 | 67.23 | 81.98 | 84.72 | 79.71 | 111.88 | 132.76 |
Average Inventory |
164.46 | 169.70 | 188.25 | 197.49 | 206.49 | 237.74 | 268.36 | 271.74 | 355.17 | 489.65 |
Average Assets |
615.62 | 647.54 | 699.18 | 755.39 | 812.71 | 886.51 | 951.55 | 976.79 | 1,171.54 | 1,431.07 |
Average Common Equity |
120.82 | 168.06 | 200.48 | 202.11 | 213.37 | 250.49 | 272.48 | 269.58 | 271.16 | 335.58 |
Columns are period end dates